Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β.

Cancer research - 1 Jun 2013

Rudolph Anja, Toth Csaba, Hoffmeister Michael, Roth Wilfried, Herpel Esther, Schirmacher Peter, Brenner Hermann, Chang-Claude Jenny

Abstract excerpt

The risk of colorectal cancer is reduced among users of oral contraceptives or menopausal hormone therapy, but associations with reproductive characteristics that are markers of a woman's endogenous hormone milieu have not been consistently observed. To help understand possible mechanisms through which exogenous and endogenous hormonal exposures are involved in colorectal cancer, we assessed the risk of these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral, Hormonal
Share to Estrogen Receptor beta

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Replacement Therapy

Share to Formaldehyde

Share to Germany

Share to Paraffin Embedding

Share to Postmenopause

Share to Tissue Fixation

Source

Identifiers

PMID: 23585455
DOI: 10.1158/0008-5472.CAN-12-4051

Genes

ESR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β.PMID 23585455Read ↗

Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.Semantic proximity Read ↗

Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.Semantic proximity Read ↗

Association of estrogen receptor-beta (ESR2) polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Oestrogen receptor-β CA repeat polymorphism is associated with incidence of colorectal cancer among females.Semantic proximity Read ↗

Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).Semantic proximity Read ↗

Estrogen receptor polymorphisms and the risk of endometrial cancer.Semantic proximity Read ↗

Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study.Semantic proximity Read ↗

Sex Steroid Receptors in Colorectal Cancer: Implications for Tumor Progression, Therapeutic Opportunities, and Sex-Specific OutcomesSemantic proximity Read ↗

Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.Semantic proximity Read ↗

Estrogen receptor-β gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake.Semantic proximity Read ↗

Estrogen Receptors in Colorectal Cancer: Facts, Novelties and PerspectivesSemantic proximity Read ↗

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.